Abstract:Background: Cyclic guanosine monophosphate (cGMP) is the common second messenger for the cardiovascular effects of nitric oxide (NO) and natriuretic peptides, such as atrial or brain natriuretic peptide, which activate the soluble and particulate forms of guanylyl cyclase, respectively. However, natriuretic peptides and NO donors exert different effects on cardiac and vascular smooth muscle function. We therefore tested whether these differences are due to an intracellular compartmentation of cGMP and evaluated the role of phosphodiesterase (PDE) subtypes in this process. Methods and results: Subsarcolemmal cGMP signals were monitored in adult rat cardiomyocytes by expression of the rat olfactory cyclic nucleotide-gated (CNG) channel alpha-subunit and recording of the associated cGMP-gated current (ICNG). Atrial natriuretic peptide (10 nmol/L) or brain natriuretic peptide (10 nmol/L) induced a clear activation of ICNG, whereas NO donors (S-nitroso-N-acetyl-penicillamine, diethylamine NONOate, 3-morpholinosydnonimine, and spermine NO, all at 100 micromol/L) had little effect. The ICNG current was strongly potentiated by nonselective PDE inhibition with isobutyl methylxanthine (100 micromol/L) and by the PDE2 inhibitors erythro-9-(2-hydroxy-3-nonyl)adenine (10 micromol/L) and Bay 60-7550 (50 nmol/L). Surprisingly, sildenafil, a PDE5 inhibitor, produced a dose-dependent increase of I(CNG) activated by NO donors but had no effect (at 100 nmol/L) on the current elicited by atrial natriuretic peptide. Conclusions: These results indicate that in rat cardiomyocytes (1) the particulate cGMP pool is readily accessible at the plasma membrane, whereas the soluble pool is not; and (2) PDE5 controls the soluble but not the particulate pool, whereas the latter is under the exclusive control of PDE2. Differential spatiotemporal distributions of cGMP may therefore contribute to the specific effects of natriuretic peptides and NO donors on cardiac function.

Molecular Physiology of Membrane Guanylyl Cyclase Receptors

Guanylate cyclase-C receptor activation: unexpected biology

Toward a Structural Understanding of Class B GPCR Peptide Binding and Activation.

Nucleotidyl Cyclase Activity of Particulate Guanylyl Cyclase A: Comparison with Particulate Guanylyl Cyclases E and F, Soluble Guanylyl Cyclase and Bacterial Adenylyl Cyclases CyaA and Edema Factor.

Control of G protein-coupled receptor function via membrane-interacting intrinsically disordered C-terminal domains

Architecture and activation of single-pass transmembrane receptor guanylyl cyclase

cDNA Display Selection of Interacting Peptide Ligands of the Guanylate Cyclase C Receptor

A Novel Insight into the Molecular Mechanism of Human Soluble Guanylyl Cyclase Focused on Catalytic Domain in Living Cells

The membrane domains of mammalian adenylyl cyclases are lipid receptors

Cyclic guanosine monophosphate compartmentation in rat cardiac myocytes

Allosteric Communication of the Dimerization and the Catalytic Domain in Photoreceptor Guanylate Cyclase

Molecular Mechanisms of GPCR Signaling: A Structural Perspective

Stimulation of guanylyl cyclase-D by bicarbonate.

Proteolytic Activation of Membrane-Bound Guanylate Cyclase.

A new Rac/PAK/GC/cGMP signaling pathway

Physiological Condition-Dependent Changes in Ciliary GPCR Localization in the Brain

The Activation Mechanism of Class-III G-Protein Coupled Receptors

Cardiac cGMP Regulation and Therapeutic Applications

Roles of GC/cGMP Signal Transduction System in Male Reproduction

A new class of receptors: Lipids regulate mammalian Gsα-stimulated adenylyl cyclase activities via their membrane anchors

Discovery of small molecule guanylyl cyclase A receptor positive allosteric modulators